Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer

Clinical Biochemistry

Volumn 42, Issue 12, 2009, Pages 1236-1245

  Crohns, Marika ^a,b   Liippo, Kari ^c   Erhola, Marina ^d   Kankaanranta, Hannu ^e,f   Moilanen, Eeva ^f   Alho, Hannu ^g,h   Kellokumpu Lehtinen, Pirkko ^a,i  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b PIRKANMAA HOSPITAL DISTRICT   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d The Municipal Joint Union For Public Health in the Hämeenlinna Region   (Finland)

^e SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antioxidants; Chemotherapy; Nitrosative stress; Oxidative stress; Small cell lung cancer

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; TUMOR MARKER; URIC ACID; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BLOOD TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HUMAN; LIPID PEROXIDATION; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NITROSATIVE STRESS; OVERALL SURVIVAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITRATES; NITRITES; OXIDATIVE STRESS; SMALL CELL LUNG CARCINOMA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 67650710814     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.05.003     Document Type: Article

References (61)

1. Cooper S., and Spiro S.G. Small cell lung cancer: treatment review. Respirology 11 (2006) 241-248
2. Ohe Y. Chemoradiotherapy for lung cancer: current status and perspectives. Int. J. Clin. Oncol. 9 (2004) 435-443
3. Stupp R., Monnerat C., Turrisi III A.T., Perry M.C., and Leyvraz S. Small cell lung cancer: state of the art and future perspectives. Lung Cancer 45 (2004) 105-117
4. Murray N., and Turrisi III A.T. A review of first-line treatment for small-cell lung cancer. J. Thorac. Oncol. 1 (2006) 270-278
5. Kurup A., and Hanna N.H. Treatment of small cell lung cancer. Crit. Rev. Oncol./Hematol. 52 (2004) 117-126
6. Look M.P., and Musch E. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 40 (1994) 8-15
7. Faure H., Coudray C., Mousseau M., et al. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic. Biol. Med. 20 (1996) 979-983
8. DeAtley S.M., Aksenov M.Y., Aksenova M.V., Carney J.M., and Butterfield D.A. Adriamycin induces protein oxidation in erythrocyte membranes. Pharmacol. Toxicol. 83 (1998) 62-68
9. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 4th (2007), Oxford University Press, Oxford, UK
10. Erhola M., Kellokumpu-Lehtinen P., Metsa-Ketela T., Alanko K., and Nieminen M.M. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radic. Biol. Med. 21 (1996) 383-390
11. Dürken M., Herrnring C., Finckh B., et al. Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic. Biol. Med. 28 (2000) 887-894
12. Kaya E., Keskin L., Aydogdu I., Kuku I., Bayraktar N., and Erkut M.A. Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma. J. Int. Med. Res. 33 (2005) 687-692
13. Nowak D., and Janczak M. Effect of chemotherapy on serum end-products of lipid peroxidation in patients with small cell lung cancer: association with treatment results. Respir. Med. 100 (2006) 157-166
14. Singal P.K., Li T., Kumar D., Danelisen I., and Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol. Cell. Biochem. 207 (2000) 77-86
15. Olson R.D., Boerth R.C., Gerber J.G., and Nies A.S. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci. 29 (1981) 1393-1401
16. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 (1994) 1029-1034
17. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
18. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment (1979), Geneva, Switzerland WHO Offset Publication No 48
19. Hu M.L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 233 (1994) 380-385
20. Salminen I., and Alfthan G. Plasma ascorbic acid preparation and storage for epidemiological studies using TCA precipitation. Clin. Biochem. 41 (2008) 723-727
21. Catignani G.L., and Bieri J.G. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin. Chem. 29 (1983) 708-712
22. Anttolainen M., Valsta L.M., Alfthan G., Kleemola P., Salminen I., and Tamminen M. Effect of extreme fish consumption on dietary and plasma antioxidant levels and fatty acid composition. Eur. J. Clin. Nutr. 50 (1996) 741-746
23. Braman R.S., and Hendrix S.A. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal. Chem. 61 (1989) 2715-2718
24. Kotikoski H., Alajuuma P., Moilanen E., et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J. Ocul. Pharmacol. Ther. 18 (2002) 11-23
25. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
26. Corongiu F.P., Lai M., and Milia A. Carbon tetrachloride, bromotrichloromethane and ethanol acute intoxication. New chemical evidence for lipid peroxidation in rat tissue microsomes. Biochem. J. 212 (1983) 625-631
27. Bird R.P., and Draper H.H. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol. 105 (1984) 299-305
28. Wayner D.D., Burton G.W., Ingold K.U., and Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett. 187 (1985) 33-37
29. Alanko J., Riutta A., Mucha I., Vapaatalo H., and Metsä-Ketelä T. Modulation of arachidonic acid metabolism by phenols: relation to positions of hydroxyl groups and peroxyl radical scavenging properties. Free Radic. Biol. Med. 14 (1993) 19-25
30. In: Tietz N.W. (Ed). Clinical Guide to Laboratory Tests. 3rd ed. (1995), WB Saunders Company, Philadelphia, PA, USA 518-519
31. Doumas B.T., Bayse D.D., Carter R.J., Peters Jr. T., and Schaffer R. A candidate reference method for determination of total protein in serum I. Development and validation. Clin. Chem. 27 (1981) 1642-1650
32. Wingerd J., and Sponzilli E.E. Concentrations of serum protein fractions in white women: effects of age, weight, smoking, tonsillectomy, and other factors. Clin. Chem. 23 (1977) 1310-1317
33. Subramaniam S., Subramaniam S., and Shyamala Devi C.S. Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients. Cancer Biochem. Biophys. 14 (1994) 177-182
34. Patel J.M. Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol. Ther. 47 (1990) 137-146
35. Schlaifer D., Cooper M.R., Attal M., et al. Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids. Leukemia 8 (1994) 668-671
36. Ames B.N., Cathcart R., Schwiers E., and Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 6858-6862
37. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., and Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem. J. 235 (1986) 747-754
38. Sevanian A., Davies K.J., and Hochstein P. Conservation of vitamin C by uric acid in blood. J. Free Radic. Biol. Med. 1 (1985) 117-124
39. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6377-6381
40. Mudway I.S., Krishna M.T., Frew A.J., et al. Compromised concentrations of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone. Occup. Environ. Med. 56 (1999) 473-481
41. Cross C.E., Motchnik P.A., Bruener B.A., et al. Oxidative damage to plasma constituents by ozone. FEBS Lett. 298 (1992) 269-272
42. Neuzil J., Gebicki J.M., and Stocker R. Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochem. J. 293 (1993) 601-606
43. Hayden M.R., and Tyagi S.C. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr. Metab. (Lond) 1 (2004) 10
44. Abiaka C., Al-Awadi F., Gulshan S., et al. Plasma concentrations of alpha-tocopherol and urate in patients with different types of cancer. J. Clin. Pharm. Ther. 26 (2001) 265-270
45. Slater T.F. Free-radical mechanisms in tissue injury. Biochem. J. 222 (1984) 1-15
46. Ohshima H., Bereziat J.C., and Bartsch H. Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index for endogenous nitrosation. Carcinogenesis 3 (1982) 115-120
47. Jonas C.R., Puckett A.B., Jones D.P., et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am. J. Clin. Nutr. 72 (2000) 181-189
48. Clemens M.R., Ladner C., Ehninger G., et al. Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am. J. Clin. Nutr. 51 (1990) 216-219
49. Vasankari T., Kujala U., Heinonen O., Kapanen J., and Ahotupa M. Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin. Chim. Acta 234 (1995) 63-69
50. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
51. Das U. A radical approach to cancer. Med. Sci. Monit. 8 (2002) RA79-92
52. Jia L., Yu W., Wang P., Sanders B.G., and Kline K. In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostate 68 (2008) 849-860
53. Metzger I.F., Sertorio J.T.C., and Tanus-Santos J.E. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. (Oxf) 188 (2006) 123-127
54. Taysi S., Uslu C., Akcay F., and Sutbeyaz M.Y. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg. Today 33 (2003) 651-654
55. Ellis G., Adatia I., Yazdanpanah M., and Makela S.K. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin. Biochem. 31 (1998) 195-220
56. Haklar G., Sayin-Ozveri E., Yüksel M., Aktan A.O., and Yalçin A.S. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett. 165 (2001) 219-224
57. Chen Q., Espey M.G., Sun A.Y., et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 11105-11109
58. Bøhn S.K., Smeland S., Sakhi A.K., et al. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett. 238 (2006) 240-247
59. Ceccarelli J., Delfino L., Zappia E., et al. The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. Int. J. Cancer 123 (2008) 1770-1778
60. Ladas E.J., Jacobson J.S., Kennedy D.D., Teel K., Fleischauer A., and Kelly K.M. Antioxidants and cancer therapy: a systematic review. J. Clin. Oncol. 22 (2004) 517-528
61. Gordon L.I., Brown S.G., Tallman M.S., et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radic. Biol. Med. 18 (1995) 383-389